As part of the portfolio application process, you are required to either
- Review 2 journal papers
- Provide 2 sample papers you have had published in a peer reviewed journal in the last 3 years
- Provide 2 papers critically appraised as part of a formal study programme (e.g. a clinical diploma)
The papers reviewed in all options must have a focus on mental health. If necessary, the candidate may mix and match options 1, 2 and 3 provided a total of 2 papers are submitted or reviewed.
Option 1) Review of journal papers
Please review two journal papers from the following list, which has been updated for the Autumn 2022 credentialing.
Each critical appraisal should comprise no more than one typed page (A4 size) using the headings recommended by the Critical Appraisal Skills Program (CASP) or suitable alternative.
- Raynsford J, Dada C, Stansfield D, et al (2020). Impact of a specialist mental health pharmacy team on medicines optimisation in primary care for patients on a severe mental illness register: a pilot study. European Journal of Hospital Pharmacy; 27:31-35.
- Woodward, J., MacKinnon, A. & Keers, R.N (2019). Stakeholders views of medicines administration by pharmacy technicians on mental health inpatient wards. Int J Clin Pharm 41, 1332–1340
- Gorton HC, Littlewood D, Lotfallah C, Spreadbury M, Wong KL, Gooding P, et al. (2019) Current and potential contributions of community pharmacy teams to self-harm and suicide prevention: A qualitative interview study. PLoS ONE 14(9):
- Kothari, M., Maidment, I., Lyon, R. et al (2016). Medicines reconciliation in comparison with NICE guidelines across secondary care mental health organisations. Int J Clin Pharm 38, 289–295
- Semahegn A, Torpey K, Manu A, et al., 2020. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Systematic Reviews; 9: 17
- Leucht S, Crippa A, Siafis S, et. Al., 2020. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. The American Journal of Psychiatry 177: 342-353
- Phillips J, Norris S, Tallbot J, et. al., 2019. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial. The American Journal of Psychiatry, 176: 401-409
- Earley W, Guo H, Nemeth G et. al., 2018. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial, Psychopharmacology Bulletin, 20; 48(4): 62-80.
- Clarke C, Duffy L, Lewis et. al. G, 2022. Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study. Applied Health Economics and Health Policy. 20(2):269-282.
- Restelli u< Garcia-Goni M, Lew-Starowicz M, et. al., 2020. Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR. Clinical Drug Investigation, 40(9) :861-871.
- Chan B, Freeman M, Meyers C, et. al., 2020. A Systematic Review and Meta-analysis of Medications for Stimulant Use Disorders in Patients with Co-Occurring Opioid Use Disorders. Drug and Alcohol Dependence, 216.
To assist you with your review(s), please view the CASP web page: http://www.casp-uk.net/casp-tools-checklists
Option 2) Published papers
Please provide 2 sample papers you have had published in a peer reviewed journal in the last 3 years that address some aspect of mental health medicines use. You must be either the sole author or the lead author of the papers. Include a short note (not more than 250 words) outlining the strengths and weaknesses of each paper.
Option 3) Critical appraisal of papers submitted as part of a formal study programme.
Please provide 2 papers including where possible any feedback that was provided. For each task provide a short note (not more than 250 words) detailing the nature of the study programme undertaken and outlining the strengths and weaknesses of each submission.
Remember to review the competencies being assessed in this file when collating your evidence: Competencies